Table of Contents
|
|
|
|
Preface |
iv |
PART
ONE |
THE PRINCIPLES OF HEMATOLOGY |
1 |
1 |
Safety and Quality in the Hematology
Laboratory |
1 |
|
An Overview of the
Hematology Laboratory |
1 |
|
The Study of Hematology |
1 |
|
Functions of the Hematology Laboratory |
1 |
|
Safety in the
Hematology Laboratory |
2 |
|
The Safety Officer |
2 |
|
Occupational Safety and Health Administration Acts and Standards |
2 |
|
Avoiding Transmission of Infectious Diseases |
3 |
|
Immune Status: Screening and Vaccination |
5 |
|
Safe Work Practices
and Protective Techniques for Infection Control |
6 |
|
Safety Manual, Policies, and Practices |
6 |
|
Standard Precautions |
6 |
|
Handwashing |
6 |
|
Personal Protective Equipment |
7 |
|
Decontamination of Work Surfaces, Equipment, and Spills |
8 |
|
General Infection Control Safety Practices |
9 |
|
OSHA Medical Waste Standards |
11 |
|
Quality Assessment
in the Hematology Laboratory |
12 |
|
Regulations and Organizations Impacting Quality |
12 |
|
Components of Quality Assessment |
12 |
|
Nonanalytical Factors in Quality
Assessment |
12 |
|
Quality Control in
the Hematology Laboratory |
16 |
|
Terms Used in Clinical Quality Control |
16 |
|
Functions of a Quality Control Program |
17 |
|
Using Statistical Analysis of Results in Quality Assessment |
18 |
|
Other Statistical Applications in the Hema Tology Laboratory |
20 |
|
Chapter Highlights |
20 |
|
Review Questions |
21 |
|
Bibliography |
23 |
2 |
Principles of Blood Collection |
25 |
|
Quality in
Phlebotomy |
25 |
|
Quality Assessment |
25 |
|
Patient Care Partnership |
25 |
|
The Phlebotomist as Laboratory Ambassador |
26 |
|
Patients with
Special Considerations |
26 |
|
Pediatric Patients |
26 |
|
Adolescent Patients |
26 |
|
Geriatric Patients |
26 |
|
Blood Collection
Supplies and Equipment |
26 |
|
Anticoagulants |
26 |
|
Adverse Effects of Additives |
27 |
|
Safe Blood Collection |
27 |
|
Evacuated Blood Collection Tubes |
29 |
|
Anticoagulants and Additives in Evacuated Blood Tubes |
31 |
|
Capillary Blood |
31 |
|
Specimen Handling Requirements |
32 |
|
Chapter Highlights |
45 |
|
Review Questions |
47 |
|
Reference |
48 |
|
Bibliography |
48 |
3 |
Molecular Genetics and Cellular
Morphology |
50 |
|
Cellular
Infrastructure and Organization |
50 |
|
Cellular Membranes |
50 |
|
Cell Volume Homeostasis |
52 |
|
Reactive and Neoplastic Growth Processes |
53 |
|
Cytoplasmic Qrganelles
and Metabolites |
53 |
|
Cellular Inclusions and Metabolites |
54 |
|
Nuclear Characteristics |
54 |
|
Chromosomes |
56 |
|
Activities of the Nucleus |
58 |
|
The Foundations of Genetic Interactions |
60 |
|
Genetic Alterations |
61 |
|
Molecular Techniques in Hematology |
63 |
|
Minimal Residual Disease |
63 |
|
Hematopathology |
67 |
|
Gene Rearrangement Studies |
69 |
|
Chapter Highlights |
69 |
|
Review Questions |
70 |
|
Bibliography |
72 |
4 |
Hematopoiesis |
73 |
|
Hematopoiesis Defined |
73 |
|
Origin of Blood
Cells |
73 |
|
Types of Human Stem Cells |
73 |
|
Early Development of Blood Cells |
73 |
|
Bone Marrow Sites
and Function |
75 |
|
Cellular Elements of
Bone Marrow |
76 |
|
Progenitor Blood Cells |
76 |
|
Erythropoiesis |
79 |
|
Granulopoiesis |
79 |
|
Lymphopoiesis |
79 |
|
Megakaryopoiesis |
79 |
|
Other Cells Found in Bone Marrow |
79 |
|
Interleukins |
79 |
|
Hematopoietic Growth Factors |
82 |
|
Examination of
Maturing Blood Cells |
83 |
|
General Cellular Characteristics |
83 |
|
Nuclear Characteristics |
83 |
|
Cytoplasmic Characteristics |
85 |
|
Mature Blood Cells
in Peripheral Blood |
86 |
|
Chapter Highlights |
86 |
|
Review Questions |
87 |
|
Bibliography |
87 |
PART TWO |
ERYTHROCYTES |
89 |
5 |
Erythrocyte Maturation, Physiology, and
Lifecycle |
89 |
|
Erythropoiesis |
90 |
|
Erythropoietin |
90 |
|
General Characteristics of Maturation and Development |
91 |
|
Developmental Stages |
92 |
|
Reticulocytes |
94 |
|
Disorders Related to
Erythrocyte Maturation and Production |
97 |
|
Disorders of Erythropoietin |
97 |
|
Red Cell Increases |
98 |
|
Defective Nuclear Maturation |
98 |
|
Characteristics and
Biosynthesis of Hemoglobin |
98 |
|
Genetic Inheritance of Hemoglobin |
98 |
|
Chemical Composition and Configuration of Hemoglobin |
98 |
|
The Role of 2,3-Diphosphoglycerate |
99 |
|
Oxygen Dissociation and Alterations |
99 |
|
Carbon Dioxide Transport |
100 |
|
Biosynthesis of Hemoglobin |
101 |
|
Disorders Related to
Hemoglobin Biosynthesis |
104 |
|
Disorders of Heme (Porphyrin)
Synthesis |
104 |
|
Disorders of Iron Metabolism |
105 |
|
Disorders of Globulin Synthesis |
108 |
|
Ontogeny of Hemoglobin |
108 |
|
Variant Forms of Normal Hemoglobin |
109 |
|
Abnormal Hemoglobin Molecules |
110 |
|
Analysis of Hemoglobin |
110 |
|
Membrane Characteristics
and Metabolic Activities of Erythrocytes |
111 |
|
Membrane Characteristics |
112 |
|
Cytoplasmic Characteristics |
113 |
|
Metabolic Activities |
113 |
|
Catabolism of Erythrocytes |
114 |
|
Measurement of
Erythrocytes |
116 |
|
Mean Corpuscular Volume |
116 |
|
Mean Corpuscular Hemoglobin |
117 |
|
Mean Corpuscular Hemoglobin Concentration |
117 |
|
Chapter Highlights |
118 |
|
Case Studies |
119 |
|
Review Questions |
121 |
|
Bibliography |
124 |
6 |
Erythrocyte Morphology and Inclusions |
126 |
|
Erythrocytes: Normal
and Abnormal |
126 |
|
Types of Variations
in Erythrocyte Size |
126 |
|
Kinds of Variations
in Erythrocyte Shape |
127 |
|
Alterations in
Erythrocyte Color |
134 |
|
Varieties of
Erythrocyte Inclusions |
135 |
|
Alterations in
Erythrocyte Distribution |
137 |
|
Parasitic Inclusions
in Erythrocytes |
137 |
|
Malaria |
137 |
|
Other Parasitic Inclusions |
141 |
|
Chapter Highlights |
142 |
|
Case Study |
142 |
|
Review Questions |
143 |
|
Bibliography |
144 |
7 |
Classification and Laboratory
Assessment of Anemias |
145 |
|
Causes of Anemia |
145 |
|
Clinical Signs and
Symptoms of Anemia |
145 |
|
Classification of Anemias |
145 |
|
Laboratory
Assessment of Anemias |
146 |
|
Quantitative Measurements of Anemia |
147 |
|
Semiquanlitaiive Grading of
Erythrocyte Morphology |
147 |
|
Supplementary Assessment of Anemias |
148 |
|
Chapter Highlights |
148 |
|
Review Questions |
148 |
|
Bibliography |
149 |
8 |
Acute and Chronic Blood Loss Anemias |
150 |
|
Acute Blood Loss
Anemia |
150 |
|
Etiology |
150 |
|
Physiology |
150 |
|
Laboratory Findings |
150 |
|
Chronic Blood Loss
Anemia |
150 |
|
Etiology |
150 |
|
Chapter Highlights |
151 |
|
Case Studies |
151 |
|
Review Questions |
153 |
|
Bibliography |
153 |
9 |
Aplastic and Related Anemias |
154 |
|
Aplastic Anemia |
154 |
|
Etiology |
154 |
|
Pathophysiology |
155 |
|
Clinical Features |
158 |
|
Laboratory Findings |
158 |
|
Treatment |
158 |
|
Congenital Red Blood
Cell-Related Disorders |
159 |
|
Telomeres |
159 |
|
Laboratory Findings in Bone Marrow Failure Syndromes |
160 |
|
Pure Red Cell Aplasia |
160 |
|
Diamond- Blackfan Anemia |
160 |
|
Fanconi Anemia |
161 |
|
Transient Erythroblastopenia of Childhood |
162 |
|
Congenital Dyserythropaietic Anemia |
163 |
|
Chapter Highlights |
163 |
|
Case Studies |
163 |
|
Review Questions |
165 |
|
Bibliography |
165 |
10 |
Iron Deficiency Anemia and Anemia of
Chronic Inflammation |
166 |
|
Scope of the Problem |
166 |
|
Iron Deficiency
Anemia |
166 |
|
Early Diagnosis |
166 |
|
Etiology |
166 |
|
Epidemiology |
167 |
|
Physiology |
168 |
|
Pathophysioiogy |
169 |
|
Clinical Signs and Symptoms |
170 |
|
Laboratory Characteristics |
170 |
|
Anemia of
Inflammation or Anemia of Chronic Disorders |
173 |
|
Etiology |
173 |
|
Pathophysiology |
173 |
|
Laboratory Characteristics |
174 |
|
Treatment |
175 |
|
Chapter Highlights |
175 |
|
Case Studies |
176 |
|
Review Questions |
179 |
|
Bibliography |
180 |
11 |
Megaloblastic Anemias |
181 |
|
Megaloblastic Anemias |
181 |
|
Etiology |
181 |
|
Epidemiology |
182 |
|
Physiology |
182 |
|
Vitamin B12 (Cobalamin)
Transport |
182 |
|
Vitamin B12 (Cobalamin) and Folk
Acid Deficiencies |
183 |
|
Pathophysiology |
184 |
|
Gastric Pathological Findings |
184 |
|
Clinical Signs and Symptoms |
186 |
|
Laboratory Findings |
186 |
|
Treatment and Monitoring Therapy |
188 |
|
Chapter Highlights |
188 |
|
Case Study |
190 |
|
Review Questions |
191 |
|
Bibliography |
191 |
12 |
Hemolytic Anemias |
192 |
|
Hemolytic Anemias |
192 |
|
Inherited Hemolytic Anemia |
192 |
|
Acquired Hemolytic Anemia |
197 |
|
Pathophysiology |
200 |
|
Diagnostic Tests |
201 |
|
Paroxysmal Nocturnal
Hemoglobinuria |
201 |
|
Etiology |
201 |
|
Epidemiology |
202 |
|
Pathophysiology |
202 |
|
Clinical Signs and Symptoms |
202 |
|
Laboratory Findings |
203 |
|
Treatment |
203 |
|
Paroxysmal Cold Hemoglobinuria |
203 |
|
Chapter Highlights |
203 |
|
Case Studies |
204 |
|
Review Questions |
207 |
|
Blbliography |
208 |
13 |
Hemoglobinopathies and Thalassemias |
210 |
|
Hemoglobin Defects |
210 |
|
Demographics |
210 |
|
Etiology |
210 |
|
Sickle Cell Disease |
211 |
|
Etiology |
212 |
|
Epidemiology |
212 |
|
Pathophysiology |
212 |
|
Clinical Signs and Symptoms |
213 |
|
General Signs and Symptoms |
214 |
|
Laboratory Testing |
214 |
|
Special Laboratory Testing |
215 |
|
Management of Sickle Cell Disease |
216 |
|
Sickle Cell
Syndromes: Pathogenesis and New Approaches |
218 |
|
Sickle β-Thalassemia |
218 |
|
Sickle-α Disease |
219 |
|
Sickle Cell Trait |
219 |
|
Thalassemia |
220 |
|
Demographics |
220 |
|
Etiology |
220 |
|
Pathophysiology |
220 |
|
β-Thalassemia |
220 |
|
α-Thalassemia |
223 |
|
Other Hemoglobinopathies |
224 |
|
Hemoglobin C Disease |
224 |
|
Hemoglobin SC Disease |
224 |
|
Hemoglobin D Disease |
224 |
|
Hemoglobin E Disease |
224 |
|
Hemoglobin H Disease |
225 |
|
Methemogiobinemia |
225 |
|
Unstable Hemoglobins |
225 |
|
Hereditary Persistance of Fetal Hemoglobin |
225 |
|
Chapter Highlights |
226 |
|
Case Studies |
227 |
|
Review Questions |
232 |
|
Bibliography |
233 |
PART THREE |
LEUKOCYTES |
235 |
14 |
Leukocytes: The Granulocytic and Monocytic Series |
235 |
|
Introduction |
235 |
|
The Granulocytic
Series |
235 |
|
Production of Neutrophils, Eosinophils, and Basophils |
235 |
|
Sites of Developmentand Maturation |
236 |
|
Development and Proliferation of Neutrophils,
Eosinophils, and Basophils |
236 |
|
Distribution of Neutrophils, Eosinophils, and Basophils |
236 |
|
Normal Maturational Characteristics of Neutrophils,
Eosinophils, and
Basophils |
237 |
|
Mature Forms |
239 |
|
Granulation in Mature Forms |
239 |
|
The Monocytic-Macrophage Series |
240 |
|
Production and Development of monocytes and
Macrophages |
240 |
|
Morphological Characteristics |
241 |
|
Reference Ranges of
Granulocytes and Monocytes |
241 |
|
Functional
Properties of Granulocytes and Monocytes |
242 |
|
General Characteristics |
243 |
|
The Role of Macrophages |
243 |
|
Acute Inflammatory Response |
243 |
|
Sepsis |
245 |
|
Steps in Phagocytosis |
245 |
|
Specialized Functions of Granulocytes |
247 |
|
Assessment Methods |
248 |
|
Total Leukocyte Count |
248 |
|
Differential Blood Smear Evaluation |
248 |
|
Absolute Cell Counts 24s |
|
|
Erythrocyte Sedimentation Rate |
248 |
|
Assessment of Eosinophils and Basophils |
249 |
|
Leukocyte Alkaline Phosphatase Test |
249 |
|
Neutrophilk Function |
249 |
|
Neutrophilic Hypersegmentation
Index |
249 |
|
Chaffer Highlights |
249 |
|
Case Study |
250 |
|
Review Questions |
251 |
|
Bibliography |
253 |
15 |
Nonmalignant Disorders of
Granulocytes and Monocytes |
254 |
|
Quantitative
Disorders |
254 |
|
Leukocytosis |
254 |
|
Leukocytopenia |
255 |
|
Morphological
Abnormalities of Mature Granulocytes |
256 |
|
Toxic Granulation |
256 |
|
Döhle Bodies |
256 |
|
Hypersegmentation |
256 |
|
Pelger-Huet Anomaly |
256 |
|
May-Hegglin Anomaly |
257 |
|
Chediak-Higashi Syndrome |
257 |
|
Alder-Reilly Inclusions |
258 |
|
Ehrlichia |
258 |
|
Abnormalities of Mature Granulocytes in Body Fluids |
258 |
|
Qualitative
Disorders |
258 |
|
Defective Locomotion and Chemotaxis |
258 |
|
Defects in Microbicida! Activity |
259 |
|
Other Functional Anomalies of Neutrophils |
259 |
|
Monocyte-Macrophage
Disorders |
259 |
|
Gaucher Disease |
259 |
|
Niemann-Pick Disease |
260 |
|
Chapter Highlights |
260 |
|
Case Studies |
260 |
|
Review Questions |
264 |
|
Bibliography |
265 |
16 |
Leukocytes: Lymphocytes and Plasma
Cells |
266 |
|
Anatomical Origin
and Development of Lymphocytes |
266 |
|
Sites Oflymphocytic Development |
266 |
|
Lymphocyte Physiology |
267 |
|
Normal Reference Values |
267 |
|
Determining Absolute Lymphocyte Values |
268 |
|
Morphological
Characteristics of Normal Lymphocytes |
268 |
|
Maturational Stages |
269 |
|
Specific Lymphocyte Morphological Variations |
272 |
|
Characteristics of
Lymphocytes |
273 |
|
Major Lymphocyte Categories and Functions |
273 |
|
Monoclonal Antibodies |
274 |
|
Major Lymphocyte Membrane Characteristics and Development |
274 |
|
Functional Testing of Lymphocytes |
277 |
|
Plasma Cell Development
and Maturation |
277 |
|
Plasma Cell Development |
277 |
|
Maturational Morphology |
277 |
|
Plasmacytoid Lymphocytes |
277 |
|
Plasma Cell Disorders |
278 |
|
Chapter Highlights |
278 |
|
Review Questions |
279 |
|
Bibliography |
280 |
17 |
Leukocytes: Nonmalignant Lymphocytic Disorders |
281 |
|
Characteristics of
Lymphocytes |
281 |
|
Lymphocytosis |
281 |
|
Disorders Associated
with Lymphocytosis |
282 |
|
Infectious Mononucleosis |
282 |
|
Cytomegalovirus Infection |
286 |
|
Toxoplasmosis |
287 |
|
Infectious Lymphocytosis |
288 |
|
Bordetetla Pertussis
(Haemophilus Pertussis) Infection |
285 |
|
Lymphocytopenia |
289 |
|
Immune Disorders
Associated with Lymphocytopenia |
289 |
|
Digeorge Syndrome |
289 |
|
Acquired Immunodeficiency Syndrome(HIV/AIDS) |
289 |
|
Systemic Lupus Erythemalosus |
293 |
|
Chapter Highlights |
294 |
|
Case Studies |
294 |
|
Review Questions |
297 |
|
Bibliography |
297 |
18 |
Characteristics of Leukemias, Lymphomas, and Myelomas |
298 |
|
Comparison of Leukemias, Lymphomas, and Myelomas |
298 |
|
Forms of Leukemia |
298 |
|
Classifications of Leukemias |
299 |
|
French-American-British Classification |
299 |
|
World Health Organization Classification |
299 |
|
Prognosis and
Treatment |
300 |
|
Factors Related to
the Occurrence of Leukemia |
300 |
|
Genetic and Immunological Factors |
300 |
|
Occupational Exposure |
302 |
|
Environmental Exposure |
302 |
|
Chemical and Drug Exposure |
302 |
|
Genetic Abnormalities and Associations |
302 |
|
Viral Agents |
303 |
|
Secondary Causes of Leukemias |
303 |
|
Demographic
Distribution of Leukemia and Lymphomas |
304 |
|
Ethnic Origin and Race |
304 |
|
Gender |
305 |
|
Chapter Highlights |
305 |
|
Review Questions |
306 |
|
Bibliography |
306 |
19 |
Acute Leukemias |
307 |
|
Introduction |
307 |
|
Epidemiology of
Acute Leukemias |
307 |
|
Prognosis of Acute Leukemias |
308 |
|
French-American-British
and World Health Organization Categories |
308 |
|
French-American-British (FAB) Classification |
308 |
|
World Health Organization (WHO) Organization Gasification |
308 |
|
General
Characteristics of Acute Myeloid Leukemias |
309 |
|
Genetic Differences |
309 |
|
Micro-RNAs |
310 |
|
Acute Myeloid Leukemia |
310 |
|
FAB M0 |
311 |
|
Acute Myeloid Leukemia (FAB Ml) |
311 |
|
Acute Myeloid Leukemia (FAB M2) |
312 |
|
Acute Promyelocytic Leukemia (FAB M3) |
312 |
|
Acute Myelomonocytic Leukemia (FAB M4) |
313 |
|
Acute Monocytic Leukemia (FAB M5) |
314 |
|
Erythrokukemk (FAB M6) |
315 |
|
Selected Examples of Unusual Forms |
316 |
|
Acute Megakaryohlastic Leukemia FAB M7 |
316 |
|
Epidemiology of
Acute Lymphoblastic Leukemia |
316 |
|
Prognosis of Acute Lymphoblastic Leukemia |
317 |
|
Classifications of
Acute Lymphoblastic Leukemia |
317 |
|
Characteristics of
Acute Lymphoblastic Leukemia |
317 |
|
Clinical Signs and Symptoms |
317 |
|
Laboratory Data |
317 |
|
Special Identification Techniques |
318 |
|
Treatment |
319 |
|
Mixed Lineage
Leukemia |
319 |
|
Cytogenetic Analysis |
319 |
|
Cytogenetic Analysis in Acute Myeloid
Leukemia |
319 |
|
Cytogenetics in Acute Lymphoblastic
Leukemia |
320 |
|
Principles of
Special Cytochemical Stains |
320 |
|
Sudan Black B Stain |
321 |
|
Myeloperoxidase Stain |
326 |
|
Periodic Acid-Schiff Stain |
322 |
|
Esterase Stains |
323 |
|
Phosphatase Stains |
324 |
|
Monoclonal
Antibodies |
325 |
|
Immunophenotyping |
325 |
|
Lymphoid |
325 |
|
Other Surface Membrane Markers |
326 |
|
Life-Threatening
Emergencies |
326 |
|
Infection |
326 |
|
Bleeding |
326 |
|
Leukemic Infiltration of Organs |
326 |
|
Metabolic Abnormalities |
326 |
|
Hyperieukocytosis |
327 |
|
Treatment Options |
327 |
|
Relapse |
328 |
|
Stem Cell Transplant |
328 |
|
Future Trends Vaccines |
328 |
|
Chapter Highlights |
328 |
|
Case Studies |
329 |
|
Review Questions |
333 |
|
Bibliography |
335 |
20 |
Lymphoid and Plasma Cell Neoplasms |
337 |
|
Mature B-Cell Neoplasms Chronic Lymphocytic
Leukemia/Small Lymphocytic Lymphoma |
337 |
|
Epidemiology |
337 |
|
Etiology |
337 |
|
Cytogenetics |
338 |
|
Molecular Genetics |
339 |
|
Staging and Prognosis |
339 |
|
Clinical Signs and Symptoms |
340 |
|
Laboratory Data |
341 |
|
Treatment Options |
341 |
|
Minimal Residual Disease |
342 |
|
Hairy Cell Leukemia |
342 |
|
Hairy Cell Leukemia Variant |
343 |
|
Prolymphocylic Leukemia |
344 |
|
Multiple Myeloma (Plasma Cell Myeloma) |
344 |
|
Epidemiology |
344 |
|
Etiology |
344 |
|
Clinical Signs and Symptoms |
344 |
|
Laboratory Data |
344 |
|
Treatment |
345 |
|
Waldenstro’m Primary Macroglobulinemia (Lymphoplasmacytic
Iymphoma) |
346 |
|
Epidemiology |
346 |
|
Etiology |
346 |
|
Clinical Signs and Symptoms |
346 |
|
Laboratory Data |
346 |
|
Treatment |
347 |
|
Lymphomas |
347 |
|
Relationship between Lymphomas and Leukemias |
347 |
|
Characteristics |
347 |
|
Categories |
347 |
|
Pathophysiology |
349 |
|
Precursors of Hodgkin Disease and B-Cell Lymphomas |
350 |
|
Hodgkin Disease |
350 |
|
Non-Hodgkin Lymphoma |
351 |
|
Characteristics of Other Forms |
352 |
|
Sézary Syndrome |
353 |
|
Mature T-Cell and NK-Cell Neoplasms |
353 |
|
Chapter Highlights |
353 |
|
Case Studies |
354 |
|
Review Questions |
358 |
|
Bibliography |
358 |
PART FOUR |
MYELOPROLIFERATIVE NEOPLASMS |
361 |
21 |
Myeloproliferative Neoplasms |
361 |
|
General Characteristics
of Mycloproliferativc Neoplasms |
362 |
|
Relationship of the Myeloproliferative Neoplasms |
362 |
|
Common Disorders Ofhemostasis and
Coagulation |
362 |
|
Prognosis and Treatment |
363 |
|
Chronic Myelogenous Leukemia |
363 |
|
Epidemiology |
363 |
|
Pathophysiology |
363 |
|
Cytogenetics |
364 |
|
Genetic Alterations |
364 |
|
Laboratory Data |
365 |
|
Cytogenetk Studies |
367 |
|
Prognosis and Treatment |
367 |
|
Minimal Residual Disease |
368 |
|
Leukemia-Specific Targets |
369 |
|
Allogeneic Bone Marrow Transplantation |
370 |
|
Polycythemia Vera, Essential Thrombocytosis (Essential Thrombocythemia),
and Primary Myelofibrois |
370 |
|
Polycythemia Vera |
370 |
|
Epidemiology |
370 |
|
Etiology |
370 |
|
Pathophysiology |
370 |
|
Karyotype |
371 |
|
Clinical Signs and Symptoms |
371 |
|
Laboratory Data |
371 |
|
Abnormalities of Hemostasis and Coagulation |
372 |
|
Other Laboratory Assays |
372 |
|
Treatment |
373 |
|
Prognosis and Complications |
374 |
|
Primary Myelofibrosis |
374 |
|
Epidemiology |
374 |
|
Pathophysiology |
374 |
|
Karyotype |
375 |
|
Clinical Signs and Symptoms |
375 |
|
Cellular Aiterations |
375 |
|
Prognosis |
376 |
|
Treatment |
376 |
|
Essential Thrombocytosis/Essential Thrombocythemia |
376 |
|
Diagnostic Characteristics |
376 |
|
Epidemiology |
377 |
|
Pathophysiology |
377 |
|
Karyotype |
377 |
|
Clinical Signs and Symptoms |
377 |
|
Laboratory Findings |
377 |
|
Relationship of Thrombocythemia and PV |
377 |
|
Treatment |
378 |
|
Chapter Highlights |
378 |
|
Case Studies |
379 |
|
Review Questions |
382 |
|
Bibliography |
384 |
22 |
Myelodysplastic Syndromes and Myelodysplastic/ Myeloproliferative
Neoplasms |
386 |
|
Classification |
386 |
|
Myelodysplastic Syndromes |
386 |
|
Myelodysplastic/Myeloproliferative Neoplasms |
386 |
|
Pathophysiology |
387 |
|
Myelodysplastic Syndrome |
387 |
|
Etiology |
388 |
|
Epidemiology |
389 |
|
Chromosomal Abnormalities |
389 |
|
Clinical Signs and Symptoms |
390 |
|
Laboratory Manifestations |
390 |
|
Features of Selected Types of Myelodysplastic
Syndromes |
391 |
|
Myelodysplastic/Myeloproliferative Neoplasms |
392 |
|
Chronic Myelomonocytic Leukemia |
392 |
|
Other Classifications |
393 |
|
Treatment Strategies |
393 |
|
Relationship of Karyotype to Prognosis |
394 |
|
Chapter Highlights |
395 |
|
Case Studies |
396 |
|
Review Questions |
397 |
|
Bibliography |
398 |
PART FIVE |
PRINCIPLES AND DISORDERS OF HEMOSTASIS AND THROMBOSIS |
399 |
23 |
Principles of Hemostasis
and Thrombosis |
399 |
|
Overview of Hemostasis and Thrombosis |
400 |
|
Blood Vasculature:
Structure and Function |
400 |
|
Arteries and Veins |
400 |
|
Arterioles and Venules |
400 |
|
Capillaries |
400 |
|
Vasculature
Physiology |
401 |
|
The Role of vasoconstriction in Hemostasis |
401 |
|
The Role of the Endothelium |
401 |
|
Maintenance of Vascular Integrity |
402 |
|
The Megakaryocytic
Cell Series |
403 |
|
General Characteristics of Megakaryocytic Development |
403 |
|
Cellular Ultrastructure of a Mature
Platelet |
405 |
|
Platelet Kinetics, Life Span, and Normal Values |
406 |
|
Platelet Function in
Hemostasis |
406 |
|
Overall Functions of Platelets |
406 |
|
Platelet Adhesion |
406 |
|
Platelet Aggregation |
407 |
|
Platelet Plug Consolidation and Stabilization |
408 |
|
Laboratory Assessment of Platelets |
408 |
|
Blood Coagulation
Factors |
410 |
|
Basic Concepts of Blood Coagulation |
410 |
|
Common Characteristics of Coagulation Factors |
410 |
|
Characteristics of Individual Factors |
410 |
|
The Mechanism of Coagulation |
413 |
|
Coagulation Pathways |
413 |
|
Thrombin-Mediated Reactions |
414 |
|
Fibrinolysis |
414 |
|
Other Systems and Inhibitors |
415 |
|
Laboratory Assessment of Blood Coagulation Factors |
416 |
|
International Normalized Ratio |
416 |
|
Specialized Assays for Coagulation Factors |
417 |
|
Anticoagulants |
417 |
|
New Thromboplastins |
418 |
|
Assays for Fibrin Formation |
419 |
|
Normal Protective
Mechanisms Against Thrombosis |
420 |
|
Normal Blood Flow |
420 |
|
Removal of Activated Clotting
Factors and Particulate Material |
420 |
|
The Natural Anticoagulant Systems |
420 |
|
Cellular Regulators |
424 |
|
Modern View of Hemostasis |
424 |
|
Chapter Highlights |
424 |
|
Review Questions |
426 |
|
Bibliography |
429 |
24 |
Disorders of Hemostasis
and Thrombosis |
431 |
|
Vascular Disorders |
431 |
|
Abnormal Platelet
Morphology |
432 |
|
Quantitative
Platelet Disorders |
432 |
|
Thrombocytopenia |
432 |
|
Thrombocytosis |
436 |
|
Qualitative
Characteristics of Platelets: Thrombocytopathy |
436 |
|
Types of Platelet Dysfunctions |
437 |
|
Bleeding Disorders
Related to Blood Clotting |
439 |
|
Defective Production |
440 |
|
Disorders of Destruction and Consumption |
445 |
|
Disorders Related to Elevated Fibrin Split Products |
449 |
|
The Hypercoagulable State |
450 |
|
Primary States of Hypercoagulability |
450 |
|
Secondary States of Hypercoagulability |
450 |
|
Pregnancy-Associated Thrombosis |
450 |
|
General Features |
451 |
|
Impaired Fibrinolysis |
454 |
|
Antithrombin III Deficiency |
456 |
|
Laboratory Assessment Of Hypercoagulable
States |
457 |
|
Chapter Highlights |
458 |
|
Case Studies |
460 |
|
Review Questions |
462 |
|
Bibliography |
463 |
PART SIX |
FUNDAMENTALS OF HEMATOLOQICAL ANALYSIS |
465 |
25 |
Body Fluid Analysis |
465 |
|
Introduction |
466 |
|
Cerebrospinal Fluid |
466 |
|
Anatomy and Physiology |
466 |
|
Production of Cerebrospinal Fluid |
466 |
|
Specimen Collection: Lumbar Puncture |
466 |
|
Laboratory Analysis |
467 |
|
Pleural, Peritoneal,
and Pericardial Fluids |
473 |
|
Effusions: Transudates and Exudates |
473 |
|
Pleural Fluid |
473 |
|
Peritoneal Fluid |
478 |
|
Pericardial Fluid |
482 |
|
Seminal Fluid |
484 |
|
Synovial Fluid |
486 |
|
Anatomy and Physiology of Joints |
486 |
|
Purpose of Arthrocentesis |
486 |
|
Aspiration |
487 |
|
Laboratory Assays |
487 |
|
Body Fluid Slide Preparation |
490 |
|
Staining of Body Fluid Sediment |
490 |
|
Amniotic Fluid |
490 |
|
Chapter Highlights |
490 |
|
Review Questions |
493 |
|
Bibliography |
496 |
26 |
Manual Procedures in Hematology |
498 |
|
Procedural Format |
498 |
|
Coagulation
Procedures |
516 |
|
Specimen Quality |
516 |
|
Special Collection Techniques |
516 |
|
Anticoagulants |
517 |
|
Specimen Handling |
517 |
|
Specimen Preparation |
517 |
|
General Sources of Error |
517 |
|
Quality Control |
518 |
|
Review Questions |
522 |
27 |
Instrumentation in Hematology |
526 |
|
Instrumental
Principles |
527 |
|
The Electrical Impedance Principle |
527 |
|
The Optical Detection Principle |
527 |
|
Characteristics of light Scatter |
527 |
|
Radio Frequency |
528 |
|
Fundamentals of Laser Technology |
528 |
|
Principles of Flow Cytometry |
529 |
|
The Basis of Cellular Identification |
529 |
|
Whole Blood Cell
Analysis |
531 |
|
Types of Automated Cell Counting Instruments |
532 |
|
General Histogram Characteristics |
543 |
|
Analysis of
Instrumental Data Output |
543 |
|
The Erythrocyte Histogram |
543 |
|
Quantitative Descriptors of Erythrocytes |
543 |
|
The Leukocyte Histogram |
544 |
|
Platelet Histograms |
545 |
|
Derived Platelet Parameters |
546 |
|
Laser Technology |
547 |
|
Red Blood Cells/Platelets 54 |
7 |
|
Peroxidase |
548 |
|
Basophil/Lobularity (Nuclear)
Channel |
549 |
|
Lymphocyte Subtyping |
549 |
|
Applications of Flow
Cytometry |
549 |
|
General Properties of Flow Cytometry |
550 |
|
Hematological Applications |
550 |
|
Clinical Applications of Flow Cytometry |
550 |
|
Other Cellular Applications |
551 |
|
Digital Microscopy |
554 |
|
Artificial Neural Networks |
554 |
|
Digital Cell Morphology |
554 |
|
Instruments in
Coagulation Studies |
555 |
|
Electromechanical Methods |
555 |
|
Photo-Optical Methods |
555 |
|
Viscosity-Based Detection System |
558 |
|
Platelet Agglutination |
559 |
|
Platelet Aggregation |
559 |
|
New Automation |
559 |
|
Summary |
559 |
|
Instrumental Principles |
559 |
|
Analysis of Electrical Impedance Instrumental Data Output |
559 |
|
Laser Technology |
560 |
|
Applications of Flow Cytometry |
560 |
|
Instruments in Coagulation Studies |
560 |
|
M Case Studies |
560 |
|
Review Questions |
569 |
|
Bibliography |
571 |
|
Appendices |
|
A |
Answers to Review Questions |
573 |
B |
The Basics of Medical Terminology |
578 |
C |
SI Units |
580 |
D |
English-Spanish Medical Phrases for
the Phlebotomist |
581 |
E |
MSDS Sheet |
582 |
F |
Tube Guide |
588 |
G |
Frequently Used Abbreviations |
590 |
|
Glossary |
591 |
|
Index |
602 |
|
|
|